Japan· JP-7223400A1045
ゴナドレリン酢酸塩
A gonadorelin product containing ゴナドレリン酢酸塩, registered in Japan by ニプロ, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Gonadorelin is registered in 5 of 19 countries.
Countries holding a registration under ATC H01CA01 (gonadorelin), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Gonadorelin · ATC H01CA01
5 / 19 countries
- Canada
- Finlandprice
- Japan
- Netherlands
- Switzerlandprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ゴナドレリン酢酸塩
- Manufacturer
- ニプロ
- Country
- Japan (JP)
- ATC code
- H01CA01
- ATC class
- Gonadorelin
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for gonadorelin.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gonadorelin · interactions on record
1 record
- 1 moderate
Most severe, free to view
- GanirelixH01CC01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H01CA01
Gonadorelin, as other registers publish it.
- FinlandCryptocurAventis Pharma Deutschland GmbH
- NetherlandsLutrelef 0,1 mg/ml, oplossing voor injectieFerring B.V.
- SwitzerlandLutrelef 3,2 mg, InjektionspräparatFerring AG
- SwitzerlandLutrelef 3,2 mg, InjektionspräparatFerring AG
- NetherlandsLutrelef 3,2 mg, poeder en oplosmiddel voor oplossing voor injectieFerring B.V.
- CanadaLUTREPULSE PWS 0.8MG/VIALFERRING INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcfd4db8-b0d4-462c-aa3d-360dfec09f16 GET /v1/drugs/dcfd4db8-b0d4-462c-aa3d-360dfec09f16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．１ｍｇ１管",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "7223400A1045",
"category": "注射薬",
"price_yen": 3283,
"generic_name": "ゴナドレリン酢酸塩",
"product_name_jp": null,
"therapeutic_class": "7223",
"transitional_expiry": null
}See everything about gonadorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.